New findings from the Cleveland Clinic suggest that elevated levels of the compound TMAO are linked to a higher chance of developing atrial fibrillation. This compound is produced in the gut after consuming foods such as red meat and egg yolks.
A 70 percent increased risk for high-TMAO individuals
The Cleveland Clinic study, which analyzed blood samples from approximately 5,000 individuals acoss the United States, found a direct correlation between gut-derived compounds and cardiac health. Researchers discovered that those with higher concentrations of trimethylamine N-oxide (TMAO) faced a 70 percent greater chance of developing atrial fibrillation compared to those with the lowest levels, as reported in the Journal of Clinical Investigation.
TMAO is not consumed directly but is generated when gut bacteria break down specific nutrients. These nutrients, including carnitine and choline, are abundant in common dietary staples such as beef steak, pork, liver, and egg yolks.. The study noted that this increased risk remained significant even after researchers adjusted for other major health factors like obesity, hypertension, and advanced age.
The role of iodomethylcholine in mouse models
Experimental research using mice has provided a potential mechanism for how these dietary choices influence heart rhythms. In these controlled environments, rodents fed diets that promoted higher TMAO levels developed atrial fibrillation more rapidly than those on standard diets.
Scientists also observed that supplementing mice with additional choline—a direct precursor to TMAO—led to an earlier onset of the condition. To combat this, researchers tested an experimental drug called iodomethylcholine, which successfully delayed the emergence of atrial fibrillation in mice by inhibiting the conversion process within the gut. However, the effectiveness of this pharmaceutical approach in human patients remains unverified.
The 1.5 million cases currently affecting the UK
The scale of atrial fibrillation is a major public health concern, particularly in the United Kingdom where the British Heart Foundation (BHF) reports that roughly 1.5 million people are currently affected. According to the BHF, diagnoses of this heart rhythm disorder surged by 50 percent in Britain between 2013 and 2023, and an estimated 270,000 additional people may be living with the condition undiagnosed.
The clinical implications of the disorder are severe, as individuals with atrial fibrillation are five times more likely to suffer a stroke. Furthermore, a 2024 Danish study published in the British Medical Journal indicated that approximately 40 percent of those with the condition will eventually develop heart failure, compared to 20 percent who will experience a stroke.
Will iodomethylcholine translate from mice to humans?
While the link between TMAO and heart health is becoming clearer, several critical questions remain regarding medical intervention. The most pressing uncertainty is whether the experimental drug iodomethylcholine can safely and effectively inhibit the choline-to-TMAO conversion in humns without causing adverse side effects.
Additionally, it remains unclear if dietary modifications alone—such as reducing the intake of red meat and eggs—are sufficient to manage risk for those already predisposed to the condition . Until human clinical trials are completed, experts suggest that the medical community cannot yet move from observing these correlations to making formal clinical recommendations for dietary changes.
Comments 0